Publications by authors named "Martin S Springer"

Claim this Profile
1
11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature.
Mingjuan J Luo, Rolf Thieringer, Martin S Springer, Samuel D Wright, Anne Hermanowski-Vosatka

Physiol Genomics· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic syndrome in mice induced by expressing a transcriptional activator in adipose tissue.
Liwen Zhang, Yuchen Zhou, Amber Ying Zhu, Xiang-qing Li, Steven S Mundt, Martin S Springer

Transgenic Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5 blockade modulates inflammation and alloimmunity in primates.
Carsten Schröder, Richard N Pierson, Bao-Ngoc H Nguyen, Douglas W Kawka, Laurence B Peterson, Martin S Springer

J Immunol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-aminothiazole-gamma-aminobutanoic amides as potent, small molecule CCR2 receptor antagonists.
Changyou Zhou, Liangqin Guo, William H Parsons, Sander G Mills, Malcolm MacCoss, Martin S Springer

Bioorg Med Chem Lett· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor.
Ronald S Veazey, Martin S Springer, Preston A Marx, Jason Dufour, Per Johan Klasse

Nat Med· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Ronald S Veazey, Per Johan Klasse, Susan M Schader, Qinxue Hu, Thomas J Ketas, Martin S Springer

Nature· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.
Anne Hermanowski-Vosatka, James M Balkovec, Kang Cheng, Howard Y Chen, Melba Hernandez, Martin S Springer

J Exp Med· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties.
Dooseop Kim, Liping Wang, Jeffrey J Hale, Christopher L Lynch, Richard J Budhu, Martin S Springer

Bioorg Med Chem Lett· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane.
Shrenik K Shah, Natalie Chen, Ravindra N Guthikonda, Sander G Mills, Lorraine Malkowitz, Martin S Springer

Bioorg Med Chem Lett· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses.
Steven M Wolinsky, Ronald S Veazey, Kevin J Kunstman, Per Johan Klasse, Jason Dufour, Martin S Springer

Virology· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor.
K Shankaran, Karla L Donnelly, Shrenik K Shah, Ravindra N Guthikonda, Malcolm MacCoss, Martin S Springer

Bioorg Med Chem Lett· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonists.
K Shankaran, Karla L Donnelly, Shrenik K Shah, Charles G Caldwell, Ping Chen, Martin S Springer

Bioorg Med Chem Lett· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains.
Dong-Ming Shen, Min Shu, Sander G Mills, Kevin T Chapman, Lorraine Malkowitz, Martin S Springer

Bioorg Med Chem Lett· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds.
Dong-Ming Shen, Min Shu, Christopher A Willoughby, Shrenik Shah, Christopher L Lynch, Martin S Springer

Bioorg Med Chem Lett· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.
Min Shu, Jennifer L Loebach, Kerry A Parker, Sander G Mills, Kevin T Chapman, Martin S Springer

Bioorg Med Chem Lett· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.
Ronald S Veazey, Per Johan Klasse, Thomas J Ketas, Jacqueline D Reeves, Michael Piatak, Martin S Springer

J Exp Med· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activity.
Christopher L Lynch, Jeffrey J Hale, Richard J Budhu, Amy L Gentry, Paul E Finke, Martin S Springer

Org Lett· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chains.
Christopher A Willoughby, Keith G Rosauer, Jeffery J Hale, Richard J Budhu, Sander G Mills, Martin S Springer

Bioorg Med Chem Lett· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of 2-aryl-4-(piperidin-1-yl)butanamines and 1,3,4-trisubstituted pyrrolidines to human CCR5: a molecular modeling-guided mutagenesis study of the binding pocket.
Laurie A Castonguay, Youmin Weng, William Adolfsen, Jerry Di Salvo, Ruth Kilburn, Martin S Springer

Biochemistry· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: modifications of the arylpropylpiperidine side chains.
Christopher L Lynch, Christopher A Willoughby, Jeffrey J Hale, Edward J Holson, Richard J Budhu, Martin S Springer

Bioorg Med Chem Lett· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activity.
Jeffrey J Hale, Richard J Budhu, Sander G Mills, Malcolm MacCoss, Sandra L Gould, Martin S Springer

Bioorg Med Chem Lett· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV.
Christopher L Lynch, Jeffrey J Hale, Richard J Budhu, Amy L Gentry, Sander G Mills, Martin S Springer

Bioorg Med Chem Lett· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional expression and characterization of macaque C-C chemokine receptor 3 (CCR3) and generation of potent antagonistic anti-macaque CCR3 monoclonal antibodies.
Liwen Zhang, Marco P Soares, Yanfen Guan, Stephen Matheravidathu, Richard Wnek, Martin S Springer

J Biol Chem· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines.
Christopher L Lynch, Amy L Gentry, Jeffrey J Hale, Sander G Mills, Malcolm MacCoss, Martin S Springer

Bioorg Med Chem Lett· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis